Barclays »

Crinetics Pharmaceuticals In shares owned by Barclays

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8M 191k 35.58
2023-09-30 $3.4M 113k 29.73
2023-06-30 $1.7M 92k 18.01
2023-03-31 $1.8M 109k 16.06
2022-12-31 $1.3M 69k 18.30
2022-09-30 $994k 51k 19.65
2022-06-30 $75k 4.0k 18.57
2022-03-31 $207k 9.5k 21.86
2021-12-31 $1.6M 58k 28.42
2021-09-30 $361k 17k 21.06
2021-06-30 $283k 15k 18.79
2021-03-31 $375k 25k 15.25
2020-12-31 $154k 11k 14.08
2020-09-30 $223k 14k 15.67
2020-06-30 $295k 17k 17.56
2020-03-31 $54k 3.7k 14.75
2019-12-31 $281k 11k 25.09
2019-09-30 $90k 6.0k 15.05
2019-06-30 $216k 8.6k 25.00
2019-03-31 $120k 5.3k 22.63
2018-09-30 $75k 2.6k 28.76